VERGANI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 6.142
AS - Asia 3.353
EU - Europa 2.672
SA - Sud America 511
Continente sconosciuto - Info sul continente non disponibili 331
AF - Africa 84
OC - Oceania 5
AN - Antartide 1
Totale 13.099
Nazione #
US - Stati Uniti d'America 5.860
SG - Singapore 1.322
IT - Italia 1.030
CN - Cina 692
VN - Vietnam 391
BR - Brasile 373
HK - Hong Kong 350
RU - Federazione Russa 349
DE - Germania 264
CA - Canada 207
SE - Svezia 201
GB - Regno Unito 159
IE - Irlanda 158
FR - Francia 115
IN - India 114
BD - Bangladesh 100
UA - Ucraina 80
ID - Indonesia 68
ES - Italia 54
NL - Olanda 52
AR - Argentina 47
TR - Turchia 46
AT - Austria 43
FI - Finlandia 43
IQ - Iraq 41
KR - Corea 41
MX - Messico 40
PL - Polonia 34
ZA - Sudafrica 34
PK - Pakistan 31
EC - Ecuador 28
JP - Giappone 25
PH - Filippine 23
BE - Belgio 17
CO - Colombia 17
UZ - Uzbekistan 17
DK - Danimarca 16
SA - Arabia Saudita 14
CH - Svizzera 13
VE - Venezuela 13
JO - Giordania 12
NP - Nepal 11
KE - Kenya 9
MA - Marocco 9
CZ - Repubblica Ceca 8
ET - Etiopia 8
JM - Giamaica 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
TN - Tunisia 7
UY - Uruguay 7
CR - Costa Rica 6
IL - Israele 6
KZ - Kazakistan 6
MY - Malesia 5
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
TH - Thailandia 5
AU - Australia 4
BO - Bolivia 4
GR - Grecia 4
NG - Nigeria 4
RO - Romania 4
AL - Albania 3
CI - Costa d'Avorio 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
PS - Palestinian Territory 3
PT - Portogallo 3
SR - Suriname 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GE - Georgia 2
GP - Guadalupe 2
GY - Guiana 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
EE - Estonia 1
IR - Iran 1
Totale 12.756
Città #
Singapore 778
Ann Arbor 652
Ashburn 589
Milan 379
Fairfield 370
Hong Kong 334
San Jose 333
Dallas 316
Woodbridge 280
Houston 217
Wilmington 208
Chandler 201
New York 196
Frankfurt am Main 170
Seattle 150
Dublin 147
Los Angeles 145
Toronto 132
Santa Clara 129
Ho Chi Minh City 121
Cambridge 120
Beijing 119
Dearborn 110
Hanoi 86
Hefei 83
Chicago 78
Jacksonville 72
Rome 68
Princeton 66
São Paulo 61
Jakarta 57
Council Bluffs 55
Buffalo 48
Lauterbourg 46
Boardman 44
The Dalles 44
Nanjing 43
Seoul 40
Columbus 39
Orem 34
Montreal 32
Lawrence 31
Vienna 28
Denver 27
Turin 26
San Francisco 25
Warsaw 25
London 23
Moscow 23
Tokyo 23
Amsterdam 22
Atlanta 22
Pune 22
Besana In Brianza 21
Chennai 21
Baghdad 20
Guangzhou 20
Johannesburg 20
Phoenix 20
San Diego 20
Altamura 19
Da Nang 19
Shanghai 19
Brooklyn 17
Egg Harbor 17
Nanchang 17
Zhengzhou 17
Munich 16
Nuremberg 16
Brussels 15
Haiphong 15
Helsinki 15
Quito 14
Tashkent 14
Lahore 13
Stockholm 13
Andover 12
Changsha 12
Mexico City 12
Ottawa 12
Rio de Janeiro 12
Salt Lake City 12
Washington 12
Bologna 11
Bắc Ninh 11
Cinisello Balsamo 11
Desio 11
Figino 11
Lappeenranta 11
Melzo 11
Zurich 11
Boston 10
Detroit 10
Hebei 10
Lachine 10
Mumbai 10
New Delhi 10
Tianjin 10
Virginia Beach 10
Amman 9
Totale 8.148
Nome #
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 598
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 378
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 376
Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation 353
TNF-related apoptosis-inducing ligand (trail)-armed exosomes deliver proapoptotic signals to tumor site 340
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy 340
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 339
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors 333
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 328
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: A case report 325
Null ABCA3 in humans: Large homozygous ABCA3 deletion, correlation to clinical-pathological findings 316
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b 304
Evidence for a role of autoinflammation in early-phase psoriasis 301
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells 299
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma 298
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 294
ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling. 291
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 288
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 276
Complex immune contextures characterise malignant peritoneal mesothelioma: Loss of adaptive immunological signature in the more aggressive histological types 258
Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3 256
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators 251
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy 250
Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3d surrogate microenvironment 248
Miaquant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices 244
Characterization of fast-twitch and slow-twitch skeletal muscles of calsequestrin 2 (CASQ2)-knock out mice: unexpected adaptive changes of fast-twitch muscles only 241
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 239
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response 238
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression 233
Pulmonary resections: Cytostructural effects of different-wavelength lasers versus electrocautery 228
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 221
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 220
A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections 217
Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro 209
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis 209
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade 203
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 194
Monkeypox: A Histopathological and Transmission Electron Microscopy Study 192
Proposal of a classification of cannulation damage in vascular access grafts based on clinical, ultrasound, and microscopic observations 190
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 190
New Techniques:The Use of Fixed-Frozen Tissue in Routine Ultrastructural Evaluation and Immunogold Labeling 188
Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22 178
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors 177
Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome 176
Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component 172
Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis 170
Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma 170
Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer 168
Genetic surfactant dysfunction in newborn infants and children with acute and chronic lung disease 145
Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes? 136
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 102
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma 93
Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome 60
Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation 56
Totale 13.099
Categoria #
all - tutte 42.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022399 0 62 63 19 26 22 16 31 24 29 47 60
2022/2023820 74 212 83 91 33 121 39 39 64 11 35 18
2023/2024701 35 56 16 28 83 201 92 23 51 5 16 95
2024/20251.957 98 211 168 105 215 126 56 69 243 267 135 264
2025/20266.131 582 379 587 559 622 292 768 261 437 519 656 469
2026/2027234 158 76 0 0 0 0 0 0 0 0 0 0
Totale 13.099